- Home
- OCGN vs UAMY Comparison
OCGN vs UAMY Comparison
Compare OCGN & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- UAMY
- Stock Information
- Founded
- OCGN 2013
- UAMY 1968
- Country
- OCGN United States
- UAMY United States
- Employees
- OCGN N/A
- UAMY N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- UAMY Metal Fabrications
- Sector
- OCGN Health Care
- UAMY Industrials
- Exchange
- OCGN Nasdaq
- UAMY Nasdaq
- Market Cap
- OCGN 283.3M
- UAMY 316.8M
- IPO Year
- OCGN N/A
- UAMY N/A
- Fundamental
- Price
- OCGN $1.03
- UAMY $4.50
- Analyst Decision
- OCGN Strong Buy
- UAMY Strong Buy
- Analyst Count
- OCGN 3
- UAMY 5
- Target Price
- OCGN $6.00
- UAMY $3.60
- AVG Volume (30 Days)
- OCGN 1.8M
- UAMY 6.3M
- Earning Date
- OCGN 08-01-2025
- UAMY 08-12-2025
- Dividend Yield
- OCGN N/A
- UAMY N/A
- EPS Growth
- OCGN N/A
- UAMY N/A
- EPS
- OCGN N/A
- UAMY N/A
- Revenue
- OCGN $4,754,000.00
- UAMY $25,728,046.00
- Revenue This Year
- OCGN N/A
- UAMY $209.07
- Revenue Next Year
- OCGN N/A
- UAMY $98.95
- P/E Ratio
- OCGN N/A
- UAMY N/A
- Revenue Growth
- OCGN N/A
- UAMY 134.91
- 52 Week Low
- OCGN $0.52
- UAMY $0.49
- 52 Week High
- OCGN $1.29
- UAMY $5.13
- Technical
- Relative Strength Index (RSI)
- OCGN 50.51
- UAMY 59.16
- Support Level
- OCGN $1.00
- UAMY $4.25
- Resistance Level
- OCGN $1.05
- UAMY $4.69
- Average True Range (ATR)
- OCGN 0.04
- UAMY 0.38
- MACD
- OCGN 0.00
- UAMY -0.05
- Stochastic Oscillator
- OCGN 55.56
- UAMY 47.88
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.